XTL Biopharmaceuticals
(NASDAQ:XTLB)
$2.55
-0.13[-4.85%]
Last update: 10:37AM Get Real Time Here
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

XTL Biopharmaceuticals Stock (NASDAQ:XTLB), Quotes and News Summary

XTL Biopharmaceuticals Stock (NASDAQ: XTLB) stock price, news, charts, stock research, profile.

Open$2.590
Close-
Volume / Avg.17.247K / 810.949K
Day Range2.510 - 2.590
52 Wk Range0.750 - 4.990
Market Cap$13.895M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
54
Short Interest-
Days to Cover1

Recent News

Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.
Avi Kapoor
Dow Surges 350 Points; Fed Holds Rates Steady
U.S. stocks traded higher toward the end of trading, after the Federal Reserve left rates unchanged. The Dow traded up 0.91% to 39,467.76 while the NASDAQ rose 1.08% to 16,341.42. The S&P 500 also rose, gaining, 0.78% to 5,218.70.
Avi Kapoor
Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession and board changes. Lifecore Biomedical shares dipped 31.7% to $4.91 on Wednesday.
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
About X.T.L. Biopharmaceuticals Ltd.
Sector
Health Care
Industry
Biotechnology
XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet ...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
XTLB
VINC

FAQ

Q

How do I buy XTL Biopharmaceuticals (XTLB) stock?

A

You can purchase shares of XTL Biopharmaceuticals (NASDAQ: XTLB) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are XTL Biopharmaceuticals's (XTLB) competitors?

A

Other companies in XTL Biopharmaceuticals’s space includes: Vincerx Pharma (NASDAQ:VINC), Eterna Therapeutics (NASDAQ:ERNA), Immuron (NASDAQ:IMRN), Dominari Holdings (NASDAQ:DOMH) and Imunon (NASDAQ:IMNN).

Q

What is the target price for XTL Biopharmaceuticals (XTLB) stock?

A

The latest price target for XTL Biopharmaceuticals (NASDAQ: XTLB) was reported by HC Wainwright & Co. on Friday, May 8, 2015. The analyst firm set a price target for 6.00 expecting XTLB to rise to within 12 months (a possible 135.29% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for XTL Biopharmaceuticals (XTLB)?

A

The stock price for XTL Biopharmaceuticals (NASDAQ: XTLB) is $2.55 last updated Today at April 16, 2024 at 10:37 AM EDT.

Q

Does XTL Biopharmaceuticals (XTLB) pay a dividend?

A

There are no upcoming dividends for XTL Biopharmaceuticals.

Q

When is XTL Biopharmaceuticals (NASDAQ:XTLB) reporting earnings?

A

XTL Biopharmaceuticals does not have any upcoming earnings scheduled.

Q

Is XTL Biopharmaceuticals (XTLB) going to split?

A

There is no upcoming split for XTL Biopharmaceuticals.

Q

What sector and industry does XTL Biopharmaceuticals (XTLB) operate in?

A

XTL Biopharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch